Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00329082
Status:
COMPLETED
Last Update Posted:
2009-10-07
First Post:
2006-05-19
Brief Title:
Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimers Disease and in Healthy Volunteers
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Study Overview
Official Title:
LY2062430 Multiple-Dose Safety in Subjects With Mild-to-Moderate Alzheimers Disease and Single-Dose Safety in Healthy Volunteers
Status:
COMPLETED
Status Verified Date:
2009-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To study the safety of LY2062430 in patients with mild-to-moderate Alzheimers disease and in healthy volunteers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| H8A-MC-LZAJ | None | None | None |